Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

SurGuard®2

Safety Hypodermic Needles

Description

Browse Gallery (5)

SurGuard®2 Safety Hypodermic Needles

Designed for convenient one-handed activation, SurGuard®2 Safety Hypodermic Needles offer a simple needlestick protection solution combined with advanced cannula and tip technologies. 

Characteristics

Simple injections


Engineered for user convenience and patient comfort, SurGuard®2 Safety Hypodermic Needles feature precision T-SharpTM technology for less painful injections.1 
 
Designed for subcutaneous, intra-muscular and intravenous injections, SurGuard®2 Safety Hypodermic Needles offer the necessary quality and supply reliability drug developers need to meet parenteral delivery challenges and product commercialization goals. 


Convenient administration

  • Simplified, one-handed activation for most injection modalities2
  • Stable, reliable, hinged sheath provides audible, visible and tangible confirmation of activation2
  • Thin wall3, low inner-diameter needles with the proven tip performance1  
  • Sheath locks around the needle for security post-administration 
  • Designed to reduce penetration resistance and injection drag forces
  • Selectable sheath position pre-administration to suit user-preference
  • Minimum training required to learn administration sequence2

Engineered for automated environments

  • Soft blister with colour tags and UDI information - allowing full device identification by on-line-vision-systems 
  • Available in a wide variety of diameters and lenghts suitable to specify most drug applications and combinations

Regulatory and Quality Aspects

  • Suited for both Luer slip tip and Luer Lock syringes 
  • In compliance with applicable ISO standards and Pharmacopoeia
  • Proven track record of reliable supply assured by global operating company 

General specifications

​SurGuard®2 Safety Hypodermic Needles are intended exclusively for subcutaneous, intra-muscular and intravenous applications.

Specification Description
Needle PointT-SharpTM Triple-bevel lancet point
CannulasStainless steel X5CrNi 18-10
HubPolypropylene
Shipping carton (standard packaging)800 pcs (8 X 100 pcs)
SterilizationIrradiation
Shelf-life5 years

Global Solutions

SurGuard®2 Safety Hypodermic Needles are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.

Downloads

Relevant product information
SurGuard 2 Leaflet 2019

References

1 Data on file 
2 Comparative Hypodermic Needle Sharpness Among Major Brands, 2009
3 Valid for cannula gauges from 18G to 25G

Let’s Find Your Best Solution

Innovation and creativity are central to Terumo Pharmaceutical Solutions’ value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.